1. Home
  2. SNSE vs CNFR Comparison

SNSE vs CNFR Comparison

Compare SNSE & CNFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNSE
  • CNFR
  • Stock Information
  • Founded
  • SNSE 2005
  • CNFR 2009
  • Country
  • SNSE United States
  • CNFR United States
  • Employees
  • SNSE N/A
  • CNFR N/A
  • Industry
  • SNSE Biotechnology: Pharmaceutical Preparations
  • CNFR Property-Casualty Insurers
  • Sector
  • SNSE Health Care
  • CNFR Finance
  • Exchange
  • SNSE Nasdaq
  • CNFR Nasdaq
  • Market Cap
  • SNSE 10.2M
  • CNFR 9.9M
  • IPO Year
  • SNSE 2021
  • CNFR 2015
  • Fundamental
  • Price
  • SNSE $8.81
  • CNFR $0.75
  • Analyst Decision
  • SNSE Strong Buy
  • CNFR
  • Analyst Count
  • SNSE 4
  • CNFR 0
  • Target Price
  • SNSE $72.50
  • CNFR N/A
  • AVG Volume (30 Days)
  • SNSE 16.6K
  • CNFR 10.6K
  • Earning Date
  • SNSE 08-05-2025
  • CNFR 08-13-2025
  • Dividend Yield
  • SNSE N/A
  • CNFR N/A
  • EPS Growth
  • SNSE N/A
  • CNFR N/A
  • EPS
  • SNSE N/A
  • CNFR 2.45
  • Revenue
  • SNSE N/A
  • CNFR $52,654,000.00
  • Revenue This Year
  • SNSE N/A
  • CNFR $25.91
  • Revenue Next Year
  • SNSE N/A
  • CNFR N/A
  • P/E Ratio
  • SNSE N/A
  • CNFR $0.31
  • Revenue Growth
  • SNSE N/A
  • CNFR N/A
  • 52 Week Low
  • SNSE $5.00
  • CNFR $0.42
  • 52 Week High
  • SNSE $17.40
  • CNFR $1.91
  • Technical
  • Relative Strength Index (RSI)
  • SNSE 58.00
  • CNFR 41.62
  • Support Level
  • SNSE $7.79
  • CNFR $0.74
  • Resistance Level
  • SNSE $8.69
  • CNFR $0.81
  • Average True Range (ATR)
  • SNSE 0.73
  • CNFR 0.05
  • MACD
  • SNSE 0.08
  • CNFR -0.01
  • Stochastic Oscillator
  • SNSE 79.72
  • CNFR 6.25

About SNSE Sensei Biotherapeutics Inc.

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).

About CNFR Conifer Holdings Inc.

Conifer Holdings Inc is an insurance holding company. The company markets and services the product offerings of the company through specialty personal insurance business lines. The company offers insurance products in Texas, Illinois, and Indiana for homeowners lines and Nevada and Michigan for other lines. The revenues of the company are derived from premiums earned from insurance operations.

Share on Social Networks: